Omzo vs Wellmedr: Compounded GLP-1 Plans and Pricing Compared
Quick verdict: For a clinician-guided program using compounded semaglutide and tirzepatide with a starting fee of $179, choose Omzo; for lower month-to-month pricing and lifetime locked-in pricing from $89/month, choose WellMedr. This Omzo vs Wellmedr comparison highlights the main differences in pricing, medication type, clinician involvement, shipping and guarantees.
Visit Omzo to review clinician-guided plans
How Omzo and WellMedr compare at a glance
Both providers connect patients with licensed clinicians and offer access to GLP-1 medications, but they emphasize different features. Use the table below to compare five clear criteria captured in the source material.
| Criteria | Omzo | WellMedr |
|---|---|---|
| Starting price | Semaglutide starting at $179; tirzepatide starting at $279 | Semaglutide plans from $89/month; semaglutide from $49/month in some plans |
| Medication type | Personalized compounded semaglutide and tirzepatide; option for prescriptions for branded meds | Compounded GLP-1 medications from licensed U.S. pharmacies; also lists branded products and plans |
| Clinical model | Clinician-guided plans reviewed by licensed U.S. providers | All treatment plans require medical evaluation and clinician approval; same-day review advertised |
| Pricing commitments | Pricing examples listed; users must confirm total cost, renewal terms and state availability | Lifetime locked-in pricing; no dose-based price increases; new customer offers advertised |
| Shipping and guarantees | Fast, discreet delivery; shipping policy noted | Free overnight shipping, on-time refills guaranteed, and a money back guarantee claim for 90 days |
Distinctive difference 1: Price model and starting costs
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279 with clinician-guided plans. WellMedr emphasizes monthly plans starting at $89/month and advertises semaglutide from $49/month in some plans and lifetime locked-in pricing. If up-front versus month-to-month cost is decisive, this is a primary distinction.
See WellMedr monthly plan options
Distinctive difference 2: Compounded medications and regulatory notes
Both sources state compounded medications are provided by licensed pharmacies and note that compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Omzo explicitly calls its primary program a Compounded Medication Program prepared by a state-licensed sterile compounding pharmacy. WellMedr also states it offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies and includes required safety notices about risks.
Check Omzo details on compounded options
Distinctive difference 3: Clinical oversight and program framing
Omzo emphasizes clinician-guided plans reviewed by licensed U.S. providers and notes clinical services are provided by third party networks of U.S.-licensed clinicians who determine eligibility and prescribe at their judgment. WellMedr requires medical evaluation and clinician approval, and highlights same-day review and clinician processes as part of its signup flow. Both require clinician review and approval before treatment.
Distinctive difference 4: Shipping, delivery and guarantee claims
Omzo lists fast, discreet delivery and mentions an included shipping policy. WellMedr advertises same-day review, free overnight shipping, on-time refills guaranteed, discreet delivery and a money back guarantee claim for 90 days if you do not lose weight. WellMedr frames more explicit delivery and refund commitments in the captured material; Omzo emphasizes clinician review and shipping availability.
Other shared considerations
Both providers advise confirming eligibility, medication, total cost, renewal terms and state availability before enrollment. Both note that individual results vary and do not guarantee weight loss.
Conclusion: Choose based on price, clinical model, and policy
In short, Omzo vs Wellmedr splits on price structure and guarantees. Choose Omzo if you want a clinician-guided program focused on personalized compounded semaglutide and tirzepatide with starting prices listed at $179 and $279 respectively and clinician-reviewed plans. Choose WellMedr if you prefer lower advertised monthly entry points from $89/month, lifetime locked-in pricing features, same-day review and explicit shipping and refund claims.